Climate Change and Neglected Tropical Diseases: Key Takeaways from the WHO-WIPO-WTO Trilateral Symposium
Neglected tropical diseases were at the forefront of a recent convening on human health and climate change.
Aparajita Lath
-
Read more: Climate Change and Neglected Tropical Diseases: Key Takeaways from the WHO-WIPO-WTO Trilateral Symposium -
Read more: Is Messenger RNA Patent-Eligible? Is Messenger RNA Patent-Eligible?
Amid ongoing patent disputes over the mRNA platform, a significant scientific question remains unanswered: whether mRNA itself even is patent eligible.
-
Read more: California Enters Insulin Manufacturing: Can We Expect to See a California Effect? California Enters Insulin Manufacturing: Can We Expect to See a California Effect?
Initiatives like CalRx may have far-reaching consequences for public health and access to medicines.
-
Read more: Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection
Recent articles emphasize the need to reform intellectual property protections for government-funded inventions of public health significance.
-
Read more: False and Deceptive Health Claims: Buyers Beware False and Deceptive Health Claims: Buyers Beware
The regulatory landscape of health-related products contains loopholes that allow false or misleading claims to proliferate.
-
Read more: FTC’s Proposed Non-Compete Rule: A Step in the Right Direction for Health Care and Biotechnology FTC’s Proposed Non-Compete Rule: A Step in the Right Direction for Health Care and Biotechnology
In January, the FTC released a draft rule that would ban non-compete clauses. This may promote competition and innovation in biotechnology.
-
Read more: COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues
An explanation of the key patents at stake in the intellectual property dispute between Moderna and Pfizer/BioNTech over COVID-19 vaccines.
-
Read more: The Secret World of mRNA: HDT Bio Corp v. Emcure and Access to Next-Gen mRNA The Secret World of mRNA: HDT Bio Corp v. Emcure and Access to Next-Gen mRNA
The future of public health in an “RNA world” is on trial in a trade secrecy dispute worth $950 million.
-
Read more: Book Review: ‘The Truth Pill: The Myth of Drug Regulation in India’ Book Review: ‘The Truth Pill: The Myth of Drug Regulation in India’
The Truth Pill is a monumental work that convincingly shows that drug regulation is but a myth in India.
-
Read more: Accessing COVID-19 mRNA Vaccines for Research: The Re-emergence of the Tragedy of the ‘Anticommons’ Accessing COVID-19 mRNA Vaccines for Research: The Re-emergence of the Tragedy of the ‘Anticommons’
COVID-19 vaccine manufacturers refusing to share samples may be the latest example of the tragedy of the “anticommons” in biomedical research.
